Targeting Oxidative Stress for Disease Prevention and Therapy: Where Do We Stand, and Where Do We Go from Here.
Cristina VassalleMaristella MaltintiLaura SabatinoPublished in: Molecules (Basel, Switzerland) (2020)
Oxidative stress (OxS) is one of the main processes related to aging and a common denominator of many different chronic/degenerative diseases (e.g., cardiovascular and neurodegenerative conditions and cancer). Thus, its potential modulation by supplementation/pharmacological therapy caused a lot of interest. However, these expectations have been mitigated by the obtainment of controversial results (beneficial, null, or adverse effects) following antioxidant interventions. Here, we discuss the current understanding of OxS assessment in health and disease, challenges and the potential of its evaluation in clinical practice, and available and future development for supplementation and pharmacologic strategies targeting OxS.
Keyphrases
- oxidative stress
- clinical practice
- dna damage
- healthcare
- cancer therapy
- diabetic rats
- ischemia reperfusion injury
- public health
- physical activity
- induced apoptosis
- papillary thyroid
- young adults
- stem cells
- bone marrow
- signaling pathway
- anti inflammatory
- human health
- replacement therapy
- drug delivery
- childhood cancer
- smoking cessation
- clinical evaluation